Daily non-political popular news in brief.
International journal group updates guidelines on registration of clinical trials
06-04-2007 · EurekAlert!The International Committee of Medical Journal Editors (ICMJE) updates its policy for registration of clinical trials, in an editorial appearing today on the organization's Web site and on the Web sites of participating journals. The update aligns ICMJE policy with the World Health Organization Clinical Trials Platform (WHO ICTRP).
Read more »
Keywords: international, journal, group, updates, guidelines, registration, clinical, trials, update, guideline, trial
« Previous | Next »
Similar news on "International journal group updates guidelines on registration of clinical trials":
- New study suggests promising drug combinations for sleeping sickness
12-08-2006 · EurekAlert!
Results from a clinical trial evaluating new drug combinations for sleeping sickness, carried out by the international humanitarian medical aid agency Medecins Sans Frontieres (MSF), and its research arm, Epicentre, have now been published in the journal PLoS Clinical Trials.
Similar news · Read more »
- Drug-based on MGH discovery may significantly improve treatment of dangerous blood disorder
01-31-2008 · EurekAlert!
Two clinical trials of the novel drug romiplostim show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura, a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital investigator, in the Feb. 2 issue of The Lancet.
Similar news · Read more »
- Drug based on MGH discovery may significantly improve treatment of dangerous blood disorder
01-31-2008 · EurekAlert!
Two clinical trials of the novel drug romiplostim show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura, a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital investigator, in the Feb. 2 issue of the Lancet.
Similar news · Read more »
- International AIDS Vaccine Initiative (IAVI) statement on male circumcision
12-14-2006 · EurekAlert!
The International AIDS Vaccine Initiative (IAVI) issued this statement today following a National Institutes of Health (NIH) decision to end two clinical trials of adult male circumcision in Uganda and Kenya. The NIH's Data Safety and Monitoring Board (DSMB), reviewing interim data, found that medically performed circumcision significantly protected men in the trial from HIV infection.
Similar news · Read more »
- New guidelines for assessing lymphoma treatment
01-23-2007 · EurekAlert!
An international team of cancer specialists and imaging experts has developed standardized guidelines for assessing lymphoma response to treatment. The guidelines will provide clinicians worldwide with uniform criteria to compare and interpret clinical trials of lymphoma treatments and should facilitate the development of new therapies.
Similar news · Read more »
- Inhaled steroids best treatment for children with asthma
01-23-2007 · EurekAlert!
Although several medications are available to help children maintain asthma control, clinical trials directly comparing them have not been conducted. In fact, current recommendations in national and international asthma guidelines are based either on studies of single treatments compared to a placebo in children or on comparison studies in adults.
Similar news · Read more »
- Penn's Abramson Cancer Center part of major phase III study for myeloma
11-21-2007 · EurekAlert!
Researchers from the UPenn's Abramson Cancer Center announced today that findings from two international clinical trials show unprecedented survival for patients with myeloma, a cancer the blood-making cells of bone marrow. Findings show that with the oral drug lenalidomide, in combination with dexamethasone, patients significantly improved by all measures where previous treatments had failed -- including a median survival of nearly three years -- the longest median survival known for this difficult to treat patient group.
Similar news · Read more »
- ADAPT safety results now published
11-16-2006 · EurekAlert!
A paper appearing this week in the Public Library of Science journal PLoS Clinical Trials presents findings from a large National Institutes of Health sponsored trial regarding the cardiovascular and cerebrovascular safety of two non-steroidal anti-inflammatory drugs, celecoxib and naproxen. The trial was initially conducted to test whether these drugs might prevent or delay the onset of Alzheimer's disease.
Similar news · Read more »
- Promising Antiobesity Drug Fails To Produce Clinically Meaningful Weight Loss
10-05-2006 · ScienceDaily
A drug designed to target a powerful hunger-stimulating factor that has long been considered a prime target for antiobesity therapy failed to produce clinically meaningful weight loss in obese people in a long-term clinical trial. People taking the drug known as MK-0557 for a year consistently lost about three pounds more than those taking a placebo, researchers reported in the October issue of the journal Cell Metabolism, published by Cell Press.
Similar news · Read more »
- New data show ACTOS(r) (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT
11-13-2006 · EurekAlert!
Researchers today presented data showing that ACTOS® (pioglitazone HCl) halted the progression of atherosclerosis as measured by carotid intima-media thickness (CIMT) in patients with type 2 diabetes. Results from the clinical trial, CHICAGO (Carotid intima-media tHICkness in Atherosclerosis using pioGlitazOne), are part of a late-breaker presentation at the American Heart Association's Scientific Sessions 2006, coincidentally being held in Chicago, and coincide with an early online issue of the Journal of the American Medical Association.
Similar news · Read more »